Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  HIV Infection

  Free Subscription


Articles published in Drugs

Retrieve available abstracts of 8 articles:
HTML format
Text format



Single Articles


    September 2018
  1. BLAIR HA
    Capsaicin 8% Dermal Patch: A Review in Peripheral Neuropathic Pain.
    Drugs. 2018 Sep 24. pii: 10.1007/s40265-018-0982.
    PubMed     Text format     Abstract available


    June 2018
  2. DEEKS ED
    Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide: A Review in HIV-1 Infection.
    Drugs. 2018 Jun 18. pii: 10.1007/s40265-018-0934.
    PubMed     Text format     Abstract available


    April 2018
  3. MARKHAM A
    Ibalizumab: First Global Approval.
    Drugs. 2018 Apr 19. pii: 10.1007/s40265-018-0907.
    PubMed     Text format     Abstract available


    March 2018
  4. MARKHAM A
    Bictegravir: First Global Approval.
    Drugs. 2018 Mar 21. pii: 10.1007/s40265-018-0896.
    PubMed     Text format     Abstract available


    January 2018
  5. SCOTT LJ
    Ledipasvir/Sofosbuvir: A Review in Chronic Hepatitis C.
    Drugs. 2018 Jan 29. pii: 10.1007/s40265-018-0864.
    PubMed     Text format     Abstract available


    December 2017
  6. PANSA P, Hsia Y, Bielicki J, Lutsar I, et al
    Evaluating Safety Reporting in Paediatric Antibiotic Trials, 2000-2016: A Systematic Review and Meta-Analysis.
    Drugs. 2017 Dec 7. pii: 10.1007/s40265-017-0850.
    PubMed     Text format     Abstract available


    October 2017
  7. DEEKS ED
    Raltegravir Once-Daily Tablet: A Review in HIV-1 Infection.
    Drugs. 2017;77:1789-1795.
    PubMed     Text format     Abstract available


    September 2017
  8. AL-SALAMA ZT
    Elsulfavirine: First Global Approval.
    Drugs. 2017 Sep 23. doi: 10.1007/s40265-017-0820.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: